Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Telesis Bio Q3 EPS $(0.42) Beats $(0.48) Estimate, Sales $6.68M Beat $5.30M Estimate

Author: Benzinga Newsdesk | November 08, 2022 05:36pm
Telesis Bio (NASDAQ:DNAY) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 23.53 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $6.68 million which beat the analyst consensus estimate of $5.30 million by 26.04 percent. This is a 139.77 percent increase over sales of $2.79 million the same period last year.

Posted In: DNAY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist